Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30193295

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2019 Jan 1
First author
Buzdar AU

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Buzdar AU
      type
      Author
    2. name
      Suman VJ
      type
      Author
    3. name
      Meric-Bernstam F
      type
      Author
    4. name
      Leitch AM
      type
      Author
    5. name
      Ellis MJ
      type
      Author
    6. name
      Boughey JC
      type
      Author
    7. name
      Unzeitig GW
      type
      Author
    8. name
      Royce ME
      type
      Author
    9. name
      Hunt KK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Buzdar AU
      type
      Author
    2. name
      Suman VJ
      type
      Author
    3. name
      Meric-Bernstam F
      type
      Author
    4. name
      Leitch AM
      type
      Author
    5. name
      Ellis MJ
      type
      Author
    6. name
      Boughey JC
      type
      Author
    7. name
      Unzeitig GW
      type
      Author
    8. name
      Royce ME
      type
      Author
    9. name
      Hunt KK
      type
      Author
    bibliography ids
    1. nci-bib-067ccd6c0a0d107ae57f9d31
    book metadata
    content sha256
    a2b7c78025c4b26cab2ef0313bd905415198c6eb73fd0f2700d285946d0e3f02
    document type
    citation
    dois
    1. 10.1001/jamaoncol.2018.3691
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30193295
    immutable id
    pubmed:30193295@a2b7c78025c4b26cab2ef0313bd905415198c6eb73fd0f2700d285946d0e3f02
    journal
    abbreviation
    JAMA Oncol
    issn electronic
    2374-2445
    issn print
    2374-2437
    issue
    1
    name
    JAMA oncology
    nlm unique id
    101652861
    pages
    45-50
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30193295
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      12af844750e09d72a9902be1027ba2620ecf3a1716cfab26a8e0cf507c11f903
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 Jan 1
      precision
      day
      year
      2019
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30193295/
      title
      Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

      Preserved source evidence · Not medical advice